Sato Pharmaceutical Inc. recalls WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and
Recalled November 20, 2019 · FDA recall D-0324-2020 · Sato Pharmaceutical
Hazard
Subpotent Drug · FDA Class III
Units
a) 112,104 units b) 24,696 units
Sold at
Nationwide within the United States, Guam and Saipan
Description
Subpotent Drug
Product
WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (NDC 0363-1407-01, UPC 3 11917-18328 2 ) and b) 18-count boxes (NDC 0363-1407-02, UPC 3 11917-20318 8) Distributed by Sato Pharmaceutical INC. 20695 S. Western Ave., Suite 240 Torrence, CA 90501,
Manufacturer(s)
Sato Pharmaceutical Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →